- Home
- GEHC vs IDXX Comparison
GEHC vs IDXX Comparison
Compare GEHC & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEHC
- IDXX
- Stock Information
- Founded
- GEHC 1892
- IDXX 1983
- Country
- GEHC United States
- IDXX United States
- Employees
- GEHC N/A
- IDXX N/A
- Industry
- GEHC Computer Software: Prepackaged Software
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GEHC Technology
- IDXX Health Care
- Exchange
- GEHC Nasdaq
- IDXX Nasdaq
- Market Cap
- GEHC 28.1B
- IDXX 34.1B
- IPO Year
- GEHC N/A
- IDXX 1991
- Fundamental
- Price
- GEHC $70.50
- IDXX $489.98
- Analyst Decision
- GEHC Strong Buy
- IDXX Buy
- Analyst Count
- GEHC 10
- IDXX 8
- Target Price
- GEHC $88.80
- IDXX $524.75
- AVG Volume (30 Days)
- GEHC 6.1M
- IDXX 998.2K
- Earning Date
- GEHC 04-30-2025
- IDXX 05-01-2025
- Dividend Yield
- GEHC 0.20%
- IDXX N/A
- EPS Growth
- GEHC 38.77
- IDXX 4.80
- EPS
- GEHC 4.76
- IDXX 10.82
- Revenue
- GEHC $19,799,000,000.00
- IDXX $3,931,836,000.00
- Revenue This Year
- GEHC $3.77
- IDXX $7.76
- Revenue Next Year
- GEHC $4.61
- IDXX $7.74
- P/E Ratio
- GEHC $14.81
- IDXX $45.31
- Revenue Growth
- GEHC 1.56
- IDXX 5.56
- 52 Week Low
- GEHC $57.65
- IDXX $356.14
- 52 Week High
- GEHC $94.80
- IDXX $548.88
- Technical
- Relative Strength Index (RSI)
- GEHC 52.42
- IDXX 72.84
- Support Level
- GEHC $66.95
- IDXX $465.00
- Resistance Level
- GEHC $71.21
- IDXX $483.91
- Average True Range (ATR)
- GEHC 2.18
- IDXX 13.82
- MACD
- GEHC 1.12
- IDXX 7.20
- Stochastic Oscillator
- GEHC 83.40
- IDXX 93.98
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.